14 Dec 2015
Enquiry// Virchow Biotech: APIs needed for the U.S. market [EN00215-EN00216-EN00217-EN00218-EN00219]
Virchow Biotech, part of the $200 million Virchow Group of Companies, equipped with facilities to manufacture products ranging from orals and topical biologicals, recombinants to parental bio-pharmaceuticals is starting development of Regadenoson, Docosanol, Azealic Acid, Fluocinonide & Desoximetasone for the U.S. market.
nagavikas@msnlabs.com
Hi,
Are you still looking for Docosanol. I'm from Maithri Drugs Private Limited (MSN group) and we can help you out with this product.
Please contact us incase you need it.
18:21, 20 Jan 2018